secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coherus Oncology, Inc. (CHRS)
CIK:        0001512762
Form:       8-K
Filed at:   2025-07-03T23:59:59+00:00
Accession:  0001558370-25-009085
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Coherus Oncology receives Nasdaq bid price deficiency notice; 180 days to regain compliance
--------------------------------------------------------------------------------

- On June 30, 2025, Nasdaq notified Coherus that its common stock closed below $1.00 for 30 consecutive business days.
- Company has until December 29, 2025 to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not compliant by deadline, Coherus may qualify for an additional 180-day period by transferring to Nasdaq Capital Market.
- Failure to cure could lead to delisting; company intends to monitor bid price and evaluate options.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1512762/000155837025009085/0001558370-25-009085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1512762/000155837025009085/chrs-20250630x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-009085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer